CINECA IRIS Institutional Research Information System

FONTANINI, GABRIELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.096
EU - Europa 7.512
AS - Asia 4.673
AF - Africa 334
SA - Sud America 316
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 9
Totale 32.955
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.585
CN - Cina 2.445
IT - Italia 2.086
DE - Germania 1.316
SE - Svezia 1.198
SG - Singapore 1.040
BG - Bulgaria 896
GB - Regno Unito 502
CA - Canada 498
TR - Turchia 489
UA - Ucraina 441
VN - Vietnam 367
FI - Finlandia 317
BR - Brasile 288
RU - Federazione Russa 234
CI - Costa d'Avorio 188
CH - Svizzera 132
HK - Hong Kong 122
AT - Austria 120
FR - Francia 100
IN - India 96
SN - Senegal 76
BE - Belgio 55
NG - Nigeria 39
NL - Olanda 25
PL - Polonia 16
AU - Australia 14
ID - Indonesia 13
ES - Italia 11
JP - Giappone 11
BD - Bangladesh 10
BJ - Benin 10
RO - Romania 10
CZ - Repubblica Ceca 9
DK - Danimarca 9
EU - Europa 9
IL - Israele 9
IQ - Iraq 8
KR - Corea 8
PK - Pakistan 8
CO - Colombia 7
AR - Argentina 6
IE - Irlanda 6
MA - Marocco 6
MX - Messico 6
AL - Albania 5
AZ - Azerbaigian 5
JO - Giordania 5
TH - Thailandia 5
EC - Ecuador 4
HU - Ungheria 4
IR - Iran 4
UZ - Uzbekistan 4
DZ - Algeria 3
EG - Egitto 3
GR - Grecia 3
LT - Lituania 3
LU - Lussemburgo 3
MD - Moldavia 3
PY - Paraguay 3
SA - Arabia Saudita 3
TW - Taiwan 3
VE - Venezuela 3
AO - Angola 2
CL - Cile 2
EE - Estonia 2
GE - Georgia 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
MY - Malesia 2
PS - Palestinian Territory 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
TN - Tunisia 2
UY - Uruguay 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
DO - Repubblica Dominicana 1
GT - Guatemala 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LY - Libia 1
MT - Malta 1
NA - Namibia 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
SC - Seychelles 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
Totale 32.955
Salva come PNG Salva come JPEG
Città #
Fairfield 2.258
Woodbridge 2.132
Chandler 1.732
Houston 1.588
Ann Arbor 1.415
Santa Clara 1.224
Ashburn 1.136
Seattle 951
Sofia 896
Wilmington 849
Cambridge 798
Shanghai 723
Beijing 594
New York 532
Singapore 511
Jacksonville 471
Ottawa 462
Boardman 426
Milan 392
Princeton 390
Lawrence 363
Izmir 327
Medford 324
Nanjing 292
Des Moines 258
Serra 246
Pisa 216
Abidjan 188
Florence 174
Dong Ket 163
Dearborn 155
Istanbul 142
Boulder 133
Bern 124
San Diego 114
Vienna 114
Hong Kong 112
Nanchang 99
Falls Church 89
Bremen 82
Kunming 82
Frankfurt am Main 79
Ogden 78
Dakar 76
Jüchen 70
London 68
Lancaster 67
Brussels 52
Hebei 50
Shenyang 50
Pune 47
Redwood City 47
Los Angeles 42
Lagos 39
Changsha 38
Jiaxing 38
Hefei 37
Fuzhou 35
Rome 35
São Paulo 31
Chicago 30
Seacroft 30
Düsseldorf 29
Tianjin 29
Washington 27
Guangzhou 26
Norwalk 24
Nürnberg 24
Dallas 23
Auburn Hills 22
Hangzhou 22
Quanzhou 21
Jinan 19
Orange 19
Phoenix 19
Toronto 18
Verona 17
Belo Horizonte 16
Kent 15
Vicopisano 15
Helsinki 14
San Francisco 14
Rho 13
Warsaw 13
Bologna 11
Changchun 11
Lucca 11
Wuhan 11
Cotonou 10
Indiana 10
Marseille 10
Turin 10
Lanzhou 9
Sezze 9
Council Bluffs 8
Edinburgh 8
Genoa 8
Redmond 8
Alessandria 7
Capannori 7
Totale 24.903
Salva come PNG Salva come JPEG
Nome #
null 346
La densità microvascolare (DMV) come marker prognostico e predittivo nelle neoplasie maligne dell'albero bronchiale in fase avanzata. 227
Antiproliferative and Proapoptotic Activity of Sunitinib on Endothelial and Anaplastic Thyroid Cancer Cells via Inhibition of Akt and ERK1/2 Phosphorylation and by Down-Regulation of Cyclin-D1. 196
Inhibition of the platelet-derived growth factor receptor beta (PDGFRB) using gene silencing, crenolanib besylate, or imatinib mesylate hampers the malignant phenotype of mesothelioma cell lines 189
CLM29, a multi-target pyrazolopyrimidine derivative, has anti-neoplastic activity in medullary thyroid cancer in vitro and in vivo 172
An atypical presentation of sporadic adult-onset centronuclear myopathy 168
CLM3, a multitarget tyrosine kinase inhibitor with antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivo 165
EGFR ligands as pharmacodynamic biomarkers in metastatic colorectal cancer patients treated with cetuximab and irinotecan 163
Novel pyrazolopyrimidine derivatives as tyrosine kinase inhibitors with antitumoral activity in vitro and in vivo in papillary dedifferentiated thyroid cancer. 163
Molecular and pathological characterization of the EZH2 rs3757441 single nucleotide polymorphism in colorectal cancer 160
Diaphragm and lung-preserving surgery with hyperthermic chemotherapy for malignant pleural mesothelioma: A 10-year experience 159
TLR9 agonist acts by different mechanisms synergizing with bevacizumab in sensitive and cetuximab-resistant colon cancer xenografts 157
Metronomic 5-fluorouracil, oxaliplatin and irinotecan in colorectal cancer. 154
Evaluation of telomerase in the development and progression of colon cancer. Int J Mol Med. 2002 Nov;10(5):589-92 152
Reply to P.M. Foye ( Letter ) 150
Second primary lung cancer and relapse: treatment and follow-up. 149
Expression and mutational status of c-kit in small-cell lung cancer: prognostic relevance 149
KRAS and BRAF mutational analyses in a phase II trial of first-line FOLFOXIRI plus bevacizumab (BV) in metastatic colorectal cancer (mCRC) patients (pts) 148
Advanced stage thymomas and thymic carcinomas: results of multimodality treatments 148
Percutaneous radiofrequency ablation (pRTA) of pulmonary tumors 146
Aberrant expression of anaplastic lymphoma kinase in lung adenocarcinoma: Analysis of circulating free tumor RNA using one-step reverse transcription-polymerase chain reaction 144
Squamous cell transformation and EGFR T790M mutation as acquired resistance mechanisms in a patient with lung adenocarcinoma treated with a tyrosine kinase inhibitor: A case report 143
EGFR and KRAS mutational analysis in a large series of Italian non-small cell lung cancer patients: 2,387 cases from a single center 143
A phase II study of intrapleural immuno-chemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy and long-term sub-cutaneous IL-2 in stage II-III malignant pleural mesothelioma 139
TERMOABLAZIONE DI NEOPLASIE POLMONARI MALIGNE: QUALI PROSPETTIVE 138
null 138
EGFR and AKT1 overexpression are mutually exclusive and associated with a poor survival in resected gastric adenocarcinomas 138
Small cell lung cancer transformation and the T790M mutation: A case report of two acquired mechanisms of TKI resistance detected in a tumor rebiopsy and plasma sample of EGFR-mutant lung adenocarcinoma 137
Distinct Angiogenic microRNA-mRNA Expression Profiles Among Subtypes of Lung Adenocarcinoma. 137
Circulating amphiregulin (AR) plasma levels as surrogate pharmacodynamic markers of EGFR inhibition with cetuximab in metastatic colorectal cancer (MCRC) patients 136
Antitumor activity of combined blockade of epidermal growth factor receptor and protein kinase A 135
Whole transcriptome targeted gene quantification provides new insights on pulmonary sarcomatoid carcinomas 135
Anaplastic lymphoma kinase gene rearrangements in cytological samples of non-small cell lung cancer: comparison with histological assessment. 133
CLM94, a novel cyclic amide with anti-VEGFR-2 and antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivo 132
Let-7g and miR-21 expression in non-small cell lung cancer: correlation with clinicopathological and molecular features 131
KIF5B/RET Rearrangement in a Carcinoma of the Thyroid Gland: A Case Report of a Fatal Disease 131
Anti-tumor activity of the combination of cetuximab, an anti-EGFR blocking monoclonal antibody and ZD6474, an inhibitor of VEGFR and EGFR tyrosine kinases 130
Mutations of Fas (APO-1/CD95) and p53 genes in nonmelanoma skin cancer 130
210P: Digital gene expression profiling to separate malignant pleural mesothelioma from benign reactive mesothelial hyperplasia 130
null 130
null 129
Alterations of Fas (APO-1/CD95) gene and its relationship with p53 in non small cell lung cancer 127
Discordant somatic and germline VEGF-A genotype in a cancer patient resistant to paclitaxel/bevacizumab with chemosensitive hepatic metastasis. 126
Analysis of Fusion Genes by NanoString System: A Role in Lung Cytology? 125
Promotion of tumour metastases and induction of angiogenesis by native HIV-1 Tat protein from BK virus/tat transgenic mice 124
Neoangiogenesis: A putative marker of malignancy in non-small-cell lung cancer (NSCLC) development 124
Irinotecan synergistically enhances the antiproliferative and proapoptotic effects of axitinib in vitro and improves its anticancer activity in vivo. 124
KIF5B/RET fusion gene analysis in a selected series of cytological specimens of EGFR, KRAS and EML4-ALK wild-type adenocarcinomas of the lung 123
Chemotherapeutic and antiangiogenic drugs beyond tumor progression in colon cancer: evaluation of the effects of switched schedules and related pharmacodynamics 123
Neoangiogenesis and p53 protein in lung cancer: Their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression 122
ANTIGENIC EXPRESSION OF M2 PYRUVATE-KINASE IN COLON RECTAL CANCER.PRELIMINARY RESULTS OF AN IMMUNOISTCHEMICAL STUDY 121
FR-MLV INFECTION INDUCES ERYTHROLEUKEMIA INSTEAD OF LYMPHOID LEUKEMIA IN MICE GIVEN PITUITARY GRAFTS 120
A high vascular count and overexpression of Vascular Endothelial Growth Factor (VEGF) are associated with unfavorable prognosis in operated Small Cell Carcinoma (SCLC) 120
Potentiation of the malignant phenotype of the undifferentiated aro thyroid cell line by insertion of the bcl-2 gene 120
Inherited germline T790M mutation and somatic epidermal growth factor receptor mutations in non-small cell lung cancer patients 120
Differential histopathologic parameters in colorectal cancer liver metastases resected after triplets plus bevacizumab or cetuximab: a pooled analysis of five prospective trials 120
Angiogenesis in intracranial meningiomas: immunohistochemical and molecular study 119
A gene-expression-based test can outperform bap1 and p16 analyses in the differential diagnosis of pleural mesothelial proliferations. 119
Accumulation of gene protein product P53 correlates with high microvessel count in non small cell lung carcinomas 117
Neoangiogenesis as prognostic indicator of survival in lung cancer. 117
Applications of tissue microarray technology in immunohistochemistry: a study on c-kit expression in small cell lung cancer 117
Nodal upstaging evaluation in NSCLC patients treated by robotic lobectomy 117
CD34 microvessel density and VEGF expression in basal and squamous cell carcinoma 116
null 116
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors. 116
miR-19a and miR-20a and tissue factor expression in activated human peripheral blood mononuclear cells 116
KRAS and BRAF mutational analyses in a phase II trial of first-line folfoxiri plus bevacizumab (BV) in metastatic colorectal cancer (MCRC) patients (pts) 114
FOLFOXIRI in combination with panitumumab as first-line treatment in quadruple wild-type (KRAS, NRAS, HRAS, BRAF) metastatic colorectal cancer patients: a phase II trial by the Gruppo Oncologico Nord Ovest (GONO). 114
MicroRNA classifiers are powerful diagnostic/prognostic tools in ALK-, EGFR-, and KRAS-driven lung cancers 114
Molecular markers and new diagnostic methods to differentiate malignant from benign mesothelial pleural proliferations: A literature review 114
Folfoxiri plus bevacizumab as first-line treatment in braf mutant metastatic colorectal cancer. 114
Screen-detected multiple primary lung cancers in the ITALUNG trial 114
Pre-treatment EGFR-T790M subclones in lung adenocarcinoma harboring activating mutation of EGFR: a positive prognostic factor for survival? 113
KRAS and BRAF genotyping of synchronous colorectal carcinomas. 113
Location of primary tumor and benefit from anti-epidermal growth factorreceptor monoclonalantibodies in patients with RAS and BRAF wild-typemetastatic colorectal cancer 113
2ND PRIMARY LUNG-CANCER AND RELAPSE - TREATMENT AND FOLLOW-UP 112
P2X7 protein expression and polymorphism in non-small cell lung cancer (NSCLC). 112
null 111
Identification of Fas (APO-1/CD95) and p53 gene mutations in non-small cell lung cancer 111
WWOX expression in different histologic types and subtypes of non-small cell lung cancer 111
null 111
Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial 111
Expression of interleukin 6 (IL-6) correlates with oestrogen receptor in human breast carcinoma 110
A preliminary study on radiofrequency thermal ablation of lung tumors 109
Analysis of NRAS mutation as poor prognostic indicator and predictor of resistance to anti-EGFR monoclonal antibodies (anti-EGFRs) in metastatic colorectal cancer (mCRC) patients (pts). 109
EGFR and AKT1 overexpression are mutually exclusive and associated with a poor survival in resected adenocarcinomas of the stomach and gastro-esophageal junction 109
Evaluation of telomerase in non-melanoma skin cancer 108
Overexpression of the cohesin-core subunit SMC1A contributes to colorectal cancer development. 107
THE EXPRESSION OF PROLIFERATING CELL NUCLEAR ANTIGEN IN PARAFFIN SECTIONS OF PERIPHERAL, NODE-NEGATIVE NON-SMALL-CELL LUNG-CANCER 106
ANGIOGENIC POTENTIAL IN-VIVO BY KAPOSIS-SARCOMA CELL-FREE SUPERNATANTS AND HIV-1 TAT PRODUCT - INHIBITION OF KS-LIKE LESIONS BY TISSUE INHIBITOR OF METALLOPROTEINASE-2 106
A high vascular count and overexpression of vascular endothelial growth factor are associated with unfavourable prognosis in operated small cell lung carcinoma 106
Novel MTCYB mutation in a young patient with recurrent stroke-like episodes and status epilepticus 106
Epidermal growth factor receptor (EGFr) expression in non-small cell lung carcinomas correlates with metastatic involvement of hilar and mediastinal lymph nodes in the squamous subtype. 106
Markers of cell proliferation as prognostic factors in differentiated thyroid cancer. 105
Efficacy of FOLFOXIRI plus bevacizumab in liver-limited metastatic colorectal cancer: A pooled analysis of clinical studies by Gruppo Oncologico del Nord Ovest 105
VALUTAZIONE DELL'ATTIVITA' TELOMERASICA E DELL'ESPRESSIONE DI hTERT mRNA IN ADENOCARCINOMA DEL COLON 104
The multimodality treatment of thymic carcinoma 104
Immunohistochemical and molecular study of radiation-induced multiple meningiomas with pleural and pulmonary metastasis 104
Distal embolization during primary angioplasty: histopathologic features and predictability 104
Gene Expression Profiling of Lung Atypical Carcinoids and Large Cell Neuroendocrine Carcinomas Identifies Three Transcriptomic Subtypes with Specific Genomic Alterations. 104
Totale 13.023
Salva come PNG Salva come JPEG
Categoria #
all - tutte 103.342
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 103.342
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.836 0 0 0 0 0 0 723 484 593 451 478 107
2020/20212.840 271 158 217 112 372 146 176 271 271 215 164 467
2021/20224.001 48 289 112 219 757 636 105 193 200 168 155 1.119
2022/20234.685 551 537 294 478 558 653 25 376 840 19 324 30
2023/20242.972 315 316 392 140 432 585 84 84 80 45 150 349
2024/20254.131 82 447 86 647 1.091 1.166 612 0 0 0 0 0
Totale 33.565